Patent ID: 8808979
Filing Date: 2014-08-19
Classification: G01N

Abstract:
1. A method for diagnosing liver enzyme induction as a predisposition for liver toxicity and diseases or disorders accompanied therewith comprising: (a) determining the amount of at least five of the following analytes: Stearic acid (C18:0), Galactose, Lignoceric acid (C24:0), Behenic acid (C22:0), Nervonic acid (C24:1), 3- and 5-Methoxysphingosine, Cholesterol, Threonic acid, Phosphatidylcholine (C18:0/C18:2), 1,2-Dioleoyl-sn-glycero-3-phosphatidyl-L-serine, Eicosapentanoic acid, Phosphatidylcholine (C18:0/C22:6) in a test bodyfluid sample of a male subject suspected to suffer from liver enzyme induction; (b) comparing the amounts determined in step (a) to a reference; and, thereby, (c) diagnosing liver enzyme induction as a predisposition for liver toxicity and diseases or disorders accompanied therewith.